Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Array BioPharma
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histologically or cytologically confirmed diagnosis of a solid tumor suitable for treatment with gemcitabine.
No more than 3 prior anticancer regimens for advanced disease.
Measurable or evaluable, nonmeasurable disease.
Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0 or 1.
Able to take and retain oral medications.
Additional criteria exist.
You may not be if
Uncontrolled or symptomatic brain metastases (if a patient has brain metastases and is on steroids, the steroid dose must have been stable for at least 30 days).
Treatment with prior chemotherapy within 21 days of first dose of study drug.
Requiring IV alimentation.
Pregnancy or lactation.
Known positive serology for the human immunodeficiency virus (HIV), hepatitis B and/or hepatitis C.
History of being unable to tolerate gemcitabine or any of its components.
